Treatment of MTRES1-associated diseases and disorders
JP2025540096APending Publication Date: 2025-12-11EMPIRICO INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- JP2025531621
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-09-26
- Filing Date
- 2023-11-30
- Publication Date
- 2025-12-11
Smart Images
Figure 2025540096000001_ABST
Abstract
Disclosed herein is a composition comprising an oligonucleotide targeting MTRES1. The oligonucleotide may comprise a small interfering RNA (siRNA) or an antisense oligonucleotide (ASO). Also provided herein is a method for treating a disease associated with a mutation in the MTRES1 gene, comprising providing an oligonucleotide targeting MTRES1 to a subject.
Need to check novelty before this filing date? Find Prior Art